Obesity and Weight Management Perspective

 
 

  • Tirzepatide: 'Exciting' and Promising in Lowering A1c   Tirzepatide is the newest player in the quest for lowering A1c in people with type 2 diabetes. Dr Anne Peters describes the novel agent -- what it can do for patients now and in the future.
  • Environmental Health Is Going to Get Very Personal Sometimes it seems that not much can be done to protect the environment, but there are steps we can take to lessen the impact on our personal health and protect that of our patients.
  • Episode 4: Better Ways to Sustain Weight Loss in Type 2 Diabetes   Patients with type 2 diabetes and obesity have more options today than ever before. Join host Dr Silvio Inzucchi and obesity expert Dr Ania Jastreboff as they discuss ways to support weight loss.
  • Combating Stress and Tackling Cortisol With increasing stressors, controlling the stress hormone cortisol is more vital than before. Dr Guttenberg offers insight into the body's response to stress and tips on how to combat it.
  • Does COVID-19 Raise the Risk for Diabetes?   Is COVID-19 responsible for new-onset diabetes? Or are COVID infections bringing to light previously undiagnosed cases? Dr Anne Peters reviews recent studies around COVID and diabetes.
  • AACE 2022 Read clinically focused news coverage of key developments from AACE 2022
  • Anorexia Nervosa in Adolescent Patients: What You Need to Know Here we will review the epidemiology, diagnosis, and treatment of anorexia, with an emphasis on what pediatricians need to know to screen and to facilitate treatment.
  • The Case for Post-COVID Steroids   Dr F. Perry Wilson cautions against changing practice on the basis of a single study.
  • Sleep More, Weigh Less? Dr Aaron Holley looks at the current association of weight gain with sleep deprivation.
  • Young Adult Obesity Has Quintupled. Will 'Cancer Wave' Follow?   Maurie Markman discusses a recent article highlighting obesity prevalence among young adults with an eye toward the implications for cancer incidence in the United States.
  • Statins for Kids: When to Pull the Trigger   The Cribsiders hit the highlights of expert recommendations for screening, diagnosis, and management of dyslipidemia in pediatric patients.
  • ECO 2022 Read clinically focused news coverage of key developments from ECO 2022
  • Apr 29 2022 This Week in Cardiology   Aspirin for primary prevention, time-restricted feeding, renal denervation, and a potential new obesity drug are the topics John Mandrola, MD, covers in this week’s podcast.
  • It's Time to Shame the Fat Shamers People with obesity are more likely to receive substandard treatment from their healthcare providers. Is bias toward people with obesity affecting your treatment of these patients?
  • Cancer Groundshot: From Blog Post to ASCO Session Bishal Gyawali, MD, PhD, looks at the rise of the cancer groundshot.
  • Type 2 Diabetes With ASCVD   Experts in endocrinology and cardiology evaluate a patient with troubling risk factors for cardiovascular disease and discuss the potential benefits of new therapies and lifestyle modifications.
  • Battling Obesity by Breaking Down Barriers Two primary care physicians detail their experiences in treating those with obesity through a community-based dedicated weight clinic after receiving their obesity medicine certification.
  • Weigh But Don't Tell Often the adolescent or preadolescent is searching for some sense of stability in a life tossed on a stormy sea roiled by hormonal and physical change.
  • Is Saturated Fat or Carbohydrates Worse for the Liver? Dr. Caroline Apovian discusses whether fat or carbohydrate overfeeding is more likely to lead to the development of nonalcoholic fatty liver disease.
  • ACC 2022 SuperWIN: Supermarket Partnership Improves DASH Diet Score   In a novel trial, DASH diet scores improved after participants were taught how to shop for healthier food, whether online or instore. Investigator Dylan Steen shares the details.